BHC logo

BHC Bausch Health Companies Inc.

New York Stock Exchange · Drug Manufacturers - Specialty & Generic · Healthcare

$8.22
-0.34 (-3.97%)

Bausch Health Companies Inc., together with its associated entities, is engaged in the development, manufacturing, and commercialization of a diverse portfolio of pharmaceutical products, medical devices, and over-the-counter remedies. Its primary therapeutic focus areas include ophthalmology, digestive health, and dermatology. The enterprise conducts its operations through five principal division…

Market Cap: $3.08Bwww.bauschhealth.com

Price

No data yet.

Social Signal Score

56
5d
50
1 mentions
—
30d
58
8 mentions
—
60d
57
12 mentions
—
90d
58
13 mentions
—
news: 13

Analyst Ratings

38 analysts
Buyconsensus
Strong Buy 0Buy 19Hold 15Sell 4Strong Sell 0
Avg price target$8.5+3.4%
Low $8Median $8.5High $9
Current Consensus

Revenue

$2.94B+22.39%
$1.66B$2.09B$2.52B$2.94B
Dec 2016Sep 2026

Analyst Estimates

FY2025
$3.87
$3.80–$3.95
4 analysts
FY2026
$5.08+31% YoY
$4.59–$5.35
3 analysts
FY2027
$4.38-14% YoY
$4.28–$4.46
4 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Thomas J. Appio
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
20,300
Beta
0.37
Country
CA
Piotroski score
6 / 9 (Middling)
Altman Z-score
0.22
www.bauschhealth.com